RNAi-combined nano-chemotherapeutics to tackle resistant tumors.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Drug Discovery Today

• Publication date

  2016-11-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.drudis.2016.06.029PMID 27380716
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Theranostic Nanoseeds for Efficacious Internal Radiation Therapy of Unresectable Solid Tumors

  2016cited by this paper
• Luteinizing hormone-releasing hormone peptide tethered nanoparticulate system for enhanced antitumoral efficacy of paclitaxel.

  2016cited by this paper
• Targeted Delivery with Imaging Assessment of siRNA Expressing Nanocassettes into Cancer.

  2016cited by this paper
• Combined Cancer Photothermal-Chemotherapy Based on Doxorubicin/Gold Nanorod-Loaded Polymersomes

  2015cited by this paper
• Generation Dependent Safety and Efficacy of Folic Acid Conjugated Dendrimer Based Anticancer Drug Formulations

  2015cited by this paper
• Platinum-based chemotherapy: gastrointestinal immunomodulation and enteric nervous system toxicity.

  2015cited by this paper
• siRNA Therapy, Challenges and Underlying Perspectives of Dendrimer as Delivery Vector.

  2015cited by this paper
• Development, Maintenance, and Reversal of Multiple Drug Resistance: At the Crossroads of TFPI1, ABC Transporters, and HIF1α

  2015cited by this paper
• Dendrimer-stabilized smart-nanoparticle (DSSN) platform for targeted delivery of hydrophobic antitumor therapeutics

  2015cited by this paper
• Nanomaterial Based Approaches for the Diagnosis and Therapy of Cardiovascular Diseases.

  2015cited by this paper
• ROP and ATRP Fabricated Dual Targeted Redox Sensitive Polymersomes Based on pPEGMA-PCL-ss-PCL-pPEGMA Triblock Copolymers for Breast Cancer Therapeutics.

  2015cited by this paper
• Editorial: Contemporary siRNA Therapeutics and the Current State-of-Art.

  2015cited by this paper
• Hollow Gold Nanoparticals as Biocompatible Radiosensitizer: An In Vitro Proof of Concept Study

  2015cited by this paper
• Chitosan Encrusted Nonionic Surfactant Based Vesicular Formulation for Topical Administration of Ofloxacin

  2015cited by this paper
• Toward rapamycin analog (rapalog)-based precision cancer therapy

  2015cited by this paper
• Dendrimer generational nomenclature: the need to harmonize.

  2015cited by this paper
• Nanocarriers Assisted siRNA Gene Therapy for the Management of Cardiovascular Disorders.

  2015cited by this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cited by this paper
• Designing hybrid onconase nanocarriers for mesothelioma therapy: a Taguchi orthogonal array and multivariate component driven analysis.

  2014cited by this paper
• Modulation of Induced Cytotoxicity of Doxorubicin by Using Apoferritin and Liposomal Cages

  2014cited by this paper
• Dendrimer, Liposomes, Carbon Nanotubes and PLGA Nanoparticles: One Platform Assessment of Drug Delivery Potential

  2014cited by this paper
• Co-delivery of Doxorubicin and Bmi1 siRNA by Folate Receptor Targeted Liposomes Exhibits Enhanced Anti-Tumor Effects in vitro and in vivo

  2014cited by this paper
• Nanoparticulate Carrier Mediated Intranasal Delivery of Insulin for the Restoration of Memory Signaling in Alzheimer's Disease

  2013cited by this paper
• Codelivery of mTERT siRNA and paclitaxel by chitosan-based nanoparticles promoted synergistic tumor suppression.

  2013cited by this paper
• A biodegradable polymersome containing Bcl-xL siRNA and doxorubicin as a dual delivery vehicle for a synergistic anticancer effect.

  2013cited by this paper
• Single-walled carbon nanotubes and graphene oxides induce autophagosome accumulation and lysosome impairment in primarily cultured murine peritoneal macrophages.

  2013cited by this paper
• Lipid modified triblock PAMAM-based nanocarriers for siRNA drug co-delivery.

  2013cited by this paper
• Polypeptide cationic micelles mediated co-delivery of docetaxel and siRNA for synergistic tumor therapy.

  2013cited by this paper
• Codelivery of VEGF siRNA and gemcitabine monophosphate in a single nanoparticle formulation for effective treatment of NSCLC.

  2013cited by this paper
• An injectable cell penetrable nano-polyplex hydrogel for localized siRNA delivery.

  2013cited by this paper
• Codelivery of an optimal drug/siRNA combination using mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo.

  2013cited by this paper
• Targeted therapy for metastatic colorectal cancer: role of aflibercept.

  2013cited by this paper
• Preparation of nano-In2O3 thin films by spray pyrolysis for gas sensing application

  2013cited by this paper
• A Biodegradable Polymersome Containing Bcl-xL siRNA and Doxorubicin as a Dual Delivery Vehicle for a Synergistic Anticancer Effect

  2013cited by this paper
• Liposomes in drug delivery: a patent review (2007 – present)

  2013cited by this paper
• STAT6 siRNA Matrix-Loaded Gelatin Nanocarriers: Formulation, Characterization, and Ex Vivo Proof of Concept Using Adenocarcinoma Cells

  2013cited by this paper
• Formulation Development and Evaluation of Hybrid Nanocarrier for Cancer Therapy: Taguchi Orthogonal Array Based Design

  2013cited by this paper
• The effect of polyethylene glycol spacer chain length on the tumor-targeting potential of folate-modified PPI dendrimers

  2013cited by this paper
• Dendrimers for Enhanced Drug Solubilization

  2013cited by this paper
• α-Fe2O3ナノ構造体の形状制御合成:改良した光触媒分解効率のための表面特性の加工

  2013cited by this paper
• Cancer targeting potential of folate targeted nanocarrier under comparative influence of tretinoin and dexamethasone.

  2013cited by this paper
• Preparation and characterization of nonaarginine-modified chitosan nanoparticles for siRNA delivery.

  2013cited by this paper
• Novel diphenyl dimethyl bicarboxylate provesicular powders with enhanced hepatocurative activity: preparation, optimization, in vitro/in vivo evaluation.

  2012cited by this paper
• Cell-penetrating peptide mimicking polymer-based combined delivery of paclitaxel and siRNA for enhanced tumor growth suppression.

  2012cited by this paper
• A review of nanocarriers for the delivery of small interfering RNA.

  2012cited by this paper
• A thermosensitive liposome prepared with a Cu²⁺ gradient demonstrates improved pharmacokinetics, drug delivery and antitumor efficacy.

  2012cited by this paper
• Exosome mimetics: a novel class of drug delivery systems

  2012cited by this paper
• Gelatin nanocarrier enables efficient delivery and phototoxicity of hypocrellin B against a mice tumour model.

  2012cited by this paper
• Enhanced apoptosis of ovarian cancer cells via nanocarrier-mediated codelivery of siRNA and doxorubicin

  2012cited by this paper
• Targeted polymersome delivery of siRNA induces cell death of breast cancer cells dependent upon Orai3 protein expression.

  2012cited by this paper
• Multifunctional nanocarrier mediated co-delivery of doxorubicin and siRNA for synergistic enhancement of glioma apoptosis in rat.

  2012cited by this paper
• Formulation approaches to short interfering RNA and MicroRNA: challenges and implications.

  2012cited by this paper
• Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance.

  2012cited by this paper
• Ethosomes and ultradeformable liposomes for transdermal delivery of clotrimazole: A comparative assessment.

  2012cited by this paper
• Experiment on the feasibility of using modified gelatin nanoparticles as insulin pulmonary administration system for diabetes therapy

  2012cited by this paper
• Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.

  2012cited by this paper
• Influence of tyrosine-derived moieties and drying conditions on the formation of helices in gelatin.

  2011cited by this paper
• Cationic Liposomal Co-delivery of Small Interfering RNA and a MEK Inhibitor for Enhanced Anticancer Efficacy

  2011cited by this paper
• Preparation and characterization of lung-targeting ceftiofur-loaded gelatin microspheres

  2011cited by this paper
• Innovative strategy for treatment of lung cancer: targeted nanotechnology-based inhalation co-delivery of anticancer drugs and siRNA

  2011cited by this paper
• Current prospects for RNA interference-based therapies

  2011cited by this paper
• In vitro release of lysozyme from gelatin microspheres: effect of cross-linking agents and thermoreversible gel as suspending medium.

  2011cited by this paper
• Co-delivery of anti-vascular endothelial growth factor siRNA and doxorubicin by multifunctional polymeric micelle for tumor growth suppression.

  2011cited by this paper
• Nanomedicine for Cancer Therapy

  2011cited by this paper
• Pulmonary toxicity of carbon nanotubes: a systematic report.

  2011cited by this paper
• In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles.

  2011cited by this paper
• Current progress of siRNA/shRNA therapeutics in clinical trials

  2011cited by this paper
• Trilysinoyl oleylamide-based cationic liposomes for systemic co-delivery of siRNA and an anticancer drug.

  2011cited by this paper
• A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA.

  2011cited by this paper
• Engineered design of mesoporous silica nanoparticles to deliver doxorubicin and P-glycoprotein siRNA to overcome drug resistance in a cancer cell line.

  2010cited by this paper
• Multidrug efflux pumps: drug binding – gates or cavity?

  2010cited by this paper
• The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance.

  2010cited by this paper
• Multifunctional Nanoparticles Delivering Small Interfering RNA and Doxorubicin Overcome Drug Resistance in Cancer*

  2010cited by this paper
• Polymersome delivery of siRNA and antisense oligonucleotides.

  2009cited by this paper
• Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.

  2009cited by this paper
• Dendimer-mediated solubilization, formulation development and in vitro-in vivo assessment of piroxicam.

  2009cited by this paper
• Targeted intracellular codelivery of chemotherapeutics and nucleic acid with a well-defined dendrimer-based nanoglobular carrier.

  2009cited by this paper
• Dendrimers as therapeutic agents: a systematic review.

  2009cited by this paper
• Exploring dendrimer towards dual drug delivery: pH responsive simultaneous drug-release kinetics

  2009cited by this paper
• Knocking down barriers: advances in siRNA delivery

  2009cited by this paper
• Dendrimers as therapeutic agents: a systematic review

  2009cited by this paper
• PEGylated PPI dendritic architectures for sustained delivery of H2 receptor antagonist.

  2009cited by this paper
• Dendrimers in oncology: an expanding horizon.

  2008cited by this paper
• Sequence- and target-independent angiogenesis suppression by siRNA via TLR3

  2008cited by this paper
• Surface-engineered dendrimers for dual drug delivery: A receptor up-regulation and enhanced cancer targeting strategy

  2008cited by this paper
• Cationic solid lipid nanoparticles reconstituted from low density lipoprotein components for delivery of siRNA.

  2008cited by this paper
• Cyclosporine A: A Review of Current Oral and Intravenous Delivery Systems

  2007cited by this paper
• Synthesis, characterization, and gene delivery of poly-L-lysine octa(3-aminopropyl)silsesquioxane dendrimers: nanoglobular drug carriers with precisely defined molecular architectures.

  2007cited by this paper
• POLYMERIC CORE‐SHELL NANOPARTICLES FOR THERAPEUTICS

  2006cited by this paper
• Influence of weak and covalent bonds on formation and hydrolysis of gelatin networks.

  2004cited by this paper
• Oral Delivery of Mycobacterium bovis BCG in a Lipid Formulation Induces Resistance to Pulmonary Tuberculosis in Mice

  2003cited by this paper
• The splice variants of vascular endothelial growth factor (VEGF) and their receptors.

  2001cited by this paper
• Genetic Immunization with Lung-Targeting Macroaggregated Polyethyleneimine-Albumin Conjugates Elicits Combined Systemic and Mucosal Immune Responses1

  2000cited by this paper
• Vascular-specific growth factors and blood vessel formation

  2000cited by this paper
• Cationic Liposomes Coated with Polyethylene Glycol As Carriers for Oligonucleotides*

  1998cited by this paper
• Mast cell numbers are increased in the smooth muscle of human sensitized isolated bronchi.

  1997cited by this paper
• MEDIATORS ON HUMAN AIRWAY SMOOTH MUSCLE

  1997cited by this paper
• A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine.

  1995cited by this paper
• Helix formation. Its involvement in the formation of gel structures.

  1975cited by this paper
• Helix formation. Its involvement in the formation of gel structures.

  1975cited by this paper

• TRAIL-Functionalized Nanoparticles in Cancer Therapy: Molecular Mechanisms and Translational Opportunities.

  2026cites this paper
• Silver nanoparticles as emerging nonviral vectors: Advances in functionalized systems for gene delivery and therapeutic targeting

  2026cites this paper
• Herbal carbon dots for wound healing: Bridging traditional phytomedicine with advanced Nanotherapeutics

  2026cites this paper
• Molecular targets in gastric cancer for nanomedicine therapeutics: mechanistic insights and translational progress

  2026cites this paper
• Microchemical and physicochemical perspectives on graphene oxide-based nanocarriers for breast Cancer therapy

  2026cites this paper
• Exploring the efficacy and mechanisms of exemestane-loaded nanoparticles in targeted breast cancer therapy.

  2025cites this paper
• PEGylated dendrimers for precision cancer therapy: Advances in tumor targeting, drug delivery, and clinical translation.

  2025cites this paper
• Redefining cancer treatment: the role of imatinib nanoparticles in precision medicine.

  2025cites this paper
• Green-synthesized silver nanoparticles: a sustainable nanoplatform for targeted colon cancer therapy.

  2025cites this paper
• Mannose directed nanoparticle delivery systems enhancing targeted cancer treatment

  2025cites this paper
• Advances in iron oxide nanoparticles for targeted breast cancer therapy: a promising nanomedicine approach

  2025cites this paper
• PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy

  2025cites this paper
• Translational Insights into Stimuli-Responsive Magnetic Nanoparticles for Breast Cancer Treatment.

  2025cites this paper
• Smart liposomal systems for brain cancer: Technological innovations in drug delivery.

  2025cites this paper
• Silver nanoparticles: Forging a new frontline in lung cancer therapy.

  2025cites this paper
• Recent advances in the clinical application of transferosomes for skin cancer management.

  2025cites this paper
• Triphenylphosphine-Based Mitochondrial Targeting Nanocarriers: Advancing Cancer Therapy

  2025cites this paper
• In-Depth Analysis of Mangiferin and Its Formulations for Alleviating Neurodegenerative Diseases: A Comprehensive Review.

  2025cites this paper
• Exploring the potential of nanoemulgels for dermatological disorders

  2025cites this paper
• Magnetic nanoparticles in cancer nanomedicine: advances in targeting, hyperthermia, and theranostics.

  2025cites this paper
• Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targeting.

  2025cites this paper
• RNA-Encapsulated Lipid Nanoparticles for Breast Cancer Therapy: Advances, Challenges, and Translational Perspectives

  2025cites this paper
• Engineering PEGylated dendrimers for targeted Cancer nanomedicine: From molecular design to therapeutic application

  2025cites this paper
• Biomimetic Modification of siRNA/Chemo Drug Nanoassemblies for Targeted Combination Therapy in Breast Cancer.

  2024cites this paper
• Enhancing Doxorubicin Efficacy with Vitamin E-TPGS Nanosystems in Cancer Therapy

  2024cites this paper
• Emerging potential of 5-Fluorouracil-loaded chitosan nanoparticles in cancer therapy

  2023cites this paper
• Targeted therapy of breast tumor by PLGA-based nanostructures: The versatile function in doxorubicin delivery.

  2023cites this paper
• Recent advancement on albumin nanoparticles in treating lung carcinoma

  2023cites this paper
• Self-nanoemulsifying drug delivery system for pancreatic cancer

  2023cites this paper
• Unravelling the enigma of siRNA and aptamer mediated therapies against pancreatic cancer

  2023cites this paper
• Recent development of aptamer conjugated chitosan nanoparticles as cancer therapeutics.

  2022cites this paper
• Developmental toxicity of nanomaterials used in drug delivery: understanding molecular biomechanics and potential remedial measures

  2022cites this paper
• Precision medicine: Ray of hope in overcoming cancer multidrug resistance.

  2022cites this paper
• A Review Article On: Amphiphilic Dendrimers And Their Biomedical Uses

  2022cites this paper
• Electrospun-Fibrous-Architecture-Mediated Non-Viral Gene Therapy Drug Delivery in Regenerative Medicine

  2022cites this paper
• Reactive oxygen nano-generators for cancer therapy

  2022cites this paper
• New paradigm in combination therapy of siRNA with chemotherapeutic drugs for effective cancer therapy

  2022cites this paper
• Delivery of Genetic Materials for the Management of Biological Disorders: Advancement and Roles of Polysaccharides and their Derivatives.

  2022cites this paper
• Clinical progress of therapeutics and vaccines: Rising hope against COVID-19 treatment

  2022cites this paper
• Therapeutic Silencing of BCL-2 Using NK Cell-Derived Exosomes as a Novel Therapeutic Approach in Breast Cancer

  2021cites this paper
• Nanopharmaceuticals: Principles and Applications Vol. 2

  2021cites this paper
• Adenosinergic Pathway: A Hope in the Immunotherapy of Glioblastoma

  2021cites this paper
• Reinforced electrospun nanofiber composites for drug delivery applications.

  2021cites this paper
• Polymer-Coated Extracellular Vesicles for Selective Codelivery of Chemotherapeutics and siRNA to Cancer Cells.

  2021cites this paper
• Recent advances of dendrimers as multifunctional nano-carriers to combat breast cancer.

  2021cites this paper
• Nanotechnology-based siRNA delivery strategies for treatment of triple negative breast cancer.

  2021cites this paper
• Types of dendrimers

  2021cites this paper
• Potential of naso-brain drug delivery in glioblastoma therapy

  2021cites this paper
• Recent Advancements and Future submissions of Silica Core-Shell Nanoparticles.

  2021cites this paper
• Multifunctional polymeric micelle-based nucleic acid delivery: Current advances and future perspectives

  2021cites this paper
• Aptamer grafted nanoparticle as targeted therapeutic tool for the treatment of breast cancer.

  2021cites this paper
• Integration of Polylactide into Polyethylenimine Facilitates the Safe and Effective Intracellular siRNA Delivery

  2020cites this paper
• Advanced nanoscale carrier-based approaches to overcome biopharmaceutical issues associated with anticancer drug 'Etoposide'.

  2020cites this paper
• Photothermal therapy as emerging combinatorial therapeutic approach

  2020cites this paper
• Mass spectrometry imaging in lipid and proteomic profiling: an emerging tool for cancer diagnosis

  2020cites this paper
• Achieving sterility in biomedical and pharmaceutical products (part-II): radiation sterilization

  2020cites this paper
• Small interfering RNA-based advanced nanoparticles for the treatment of cancer

  2020cites this paper
• Recent Advances on Nanostructured Materials for Drug Delivery and Release

  2020cites this paper
• Exosomes in multidrug-resistant cancer.

  2020cites this paper
• Recent advances in targeted nanomedicine as promising antitumor therapeutics.

  2020cites this paper
• Nucleic Acid-Based Approaches for Tumor Therapy

  2020cites this paper
• Mathematical and computational models of RNA nanoclusters and their applications in data-driven environments

  2020cites this paper
• Combinatory Treatment with miR-7-5p and Drug-Loaded Cubosomes Effectively Impairs Cancer Cells

  2020cites this paper
• Micelleplexes as nucleic acid delivery systems for cancer-targeted therapies.

  2020cites this paper
• Endosomal escape tendency of drug delivery systems to mediate cytosolic delivery of therapeutics

  2020cites this paper
• Bionanotechnology in Pharmaceutical Research

  2019cites this paper
• Targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy

  2019cites this paper
• pH/Redox Dual-Responsive Polyplex with Effective Endosomal Escape for Codelivery of siRNA and Doxorubicin against Drug-Resistant Cancer Cells.

  2019cites this paper
• Tumor Microenvironment Targeted Nanotherapeutics for Cancer Therapy and Diagnosis: A review.

  2019cites this paper
• Nasal Administration of Cationic Nanoemulsions as CD73-siRNA Delivery System for Glioblastoma Treatment: a New Therapeutical Approach

  2019cites this paper
• Hyaluronic Acid as an Emerging Technology Platform for Silencing RNA Delivery

  2019cites this paper
• Natural Polysaccharides for siRNA Delivery: Nanocarriers Based on Chitosan, Hyaluronic Acid, and Their Derivatives

  2019cites this paper
• Codelivery of DOX and siRNA by folate-biotin-quaternized starch nanoparticles for promoting synergistic suppression of human lung cancer cells

  2019cites this paper
• Nucleic Acid-Based Nanocarriers

  2019cites this paper
• Nanotechnology based approaches for anti-diabetic drugs delivery.

  2018cites this paper
• Polymer Vesicles: Modular Platforms for Cancer Theranostics

  2018cites this paper
• Enhanced endosomal escape by photothermal activation for improved small interfering RNA delivery and antitumor effect

  2018cites this paper
• Chemotherapeutic resistance: a nano-mechanical point of view

  2018cites this paper
• Carbon nanotubes (CNTs) based advanced dermal therapeutics: current trends and future potential.

  2018cites this paper
• Recent advances in the design, development, and targeting mechanisms of polymeric micelles for delivery of siRNA in cancer therapy

  2017cites this paper
• Dendrimers in Targeting and Delivery of Drugs

  2017cites this paper
• Cell Growth Inhibition Effect of DsiRNA Vectorised by Pectin-Coated Chitosan-Graphene Oxide Nanocomposites as Potential Therapy for Colon Cancer

  2017cites this paper
• The use of nanoscaffolds and dendrimers in tissue engineering.

  2017cites this paper
• Recent Advances in Oncological Submissions of Dendrimer.

  2017cites this paper
• Pharmacokinetic and Pharmacodynamic Features of Nanoemulsion Following Oral, Intravenous, Topical and Nasal Route.

  2017cites this paper
• Magnetic nanoparticles for medical applications.

  2017cites this paper
• Recent advances in exosome-based nanovehicles as RNA interference therapeutic carriers.

  2017cites this paper
• Carbon Nanotubes in Targeting and Delivery of Drugs

  2017cites this paper
• The Warburg effect and glucose-derived cancer theranostics.

  2017cites this paper
• Solid Lipid Nanoparticles for Targeting and Delivery of Drugs and Genes

  2017cites this paper
• Biopolymer-based nanocomposites for transdermal drug delivery

  2017cites this paper
• Surface Engineered Dendrimers in siRNA Delivery and Gene Silencing.

  2017cites this paper
• Nanotechnology for the Development of Nanomedicine

  2017cites this paper